Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: Sanofi  Apr 27, 2019  5 years, 2 months, 4 weeks, 1 day, 11 hours, 21 minutes ago

Anti-skin cancer drug approved in EU

Anti-skin cancer drug approved in EU
Source: Sanofi  Apr 27, 2019  5 years, 2 months, 4 weeks, 1 day, 11 hours, 21 minutes ago
French pharmaceutical giant Sanofi on Friday said the European Medicines Agency had conditionally approved its anti-cancer drug Libtayo, the first drug of its kind to be authorised for use in the EU. The drug, also known as CEMIPLIMAB-RWLC is used for for treatment of Advanced Cutaneous Squamous Cell Carcinoma



The tumour-reducing drug is aimed at patients with the second most common form of skin cancer—cutaneous squamous cell carcinoma (CSCC)—whose cancer is advanced, and who are not candidates for surgery or radiation therapy.

Confirming the conditional approval, the agency added in a statement that it had "adopted a positive opinion, recommending the granting of a conditional marketing authorisation for the medicinal product Libtayo, intended for the treatment of advanced cutaneous squamous cell carcinoma".

"The benefits with Libtayo are its ability to reduce tumour size and to prevent progression of the tumour for longer," it said.
No drugs for the treatment of CSCC are currently approved in the EU, according to Sanofi.

Final approval of the drug will be given subject to Sanofi providing further results from clinical trials.

The US Food and Drug Administration (FDA) approved Libtayo in September 2018 while Health Canada gave it the conditional green light earlier this month.
 

MOST READ

Jun 10, 2023  1 year ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Sep 08, 2022  2 years ago
Source- Medical News - COVID-19 Research - Impaired Pain Modulation
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer
Aug 13, 2020  4 years ago
Source: Supplements For COVID-19